In addition, EGCG has anticancer effect in human pancreatic carcinoma cells by inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor induction of CDK inhibitors, and inhibition of FAK and insulin-like growth factor-1 receptor [37]. This evidence concerns the gene PTK2 and exocrine pancreatic carcinoma.